Skip to main content

Rheumatoid Arthritis

      RT @RichardPAConway: Dr McDermott @jeffsparks on risk factors for RA-bronchiectasis. Seropositivity, older age at RA ons
      3 years 1 month ago
      Dr McDermott @jeffsparks on risk factors for RA-bronchiectasis. Seropositivity, older age at RA onset, and lower BMI⬆️risk. Abstr#0288 #ACR21 @RheumNow https://t.co/7d2ZVWLzn6
      RT @RichardPAConway: Dr O'Brien on co-existent AAV and RA. Not something I'm used to seeing, but maybe we need to think
      3 years 1 month ago
      Dr O'Brien on co-existent AAV and RA. Not something I'm used to seeing, but maybe we need to think about it more? 25 cases with RA+AAV, 52 with RA + ANCA but no AAV, not sure what the denominator is here though. Abstr#0428 #ACR21 @RheumNow @profgayecunnane https://t.co/fN3BRpc7UJ
      RT @RichardPAConway: Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction
      3 years 1 month ago
      Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction in fractures (very small numbers) Interesting, but need to see fracture benefit in larger study to justify dmab as first line Abstr#0445 #ACR21 @RheumNow https://t.co/GgaS9JZGzb
      RT @drdavidliew: Diabetes puts you at risk of cardiovascular disease, right?
      What about RA?
      Look at this graph and compa
      3 years 1 month ago
      Diabetes puts you at risk of cardiovascular disease, right? What about RA? Look at this graph and compare the pair. "already it was impossible to say which was which” - George Orwell, Animal Farm #ACR21 ABST0287 @RheumNow https://t.co/r0yaeC530l https://t.co/mKJhoyJ2Cn
      RT @_Castillo_Pedro: Year 2 f/u on PsA, axSpA, or RA using CT-P13, an infliximab (IFX) biosimilar. Pts either naive to I
      3 years 1 month ago
      Year 2 f/u on PsA, axSpA, or RA using CT-P13, an infliximab (IFX) biosimilar. Pts either naive to IFX or switched from IFX: 💠IFX-naive: improved disease activity 💠IFX-switched: maintained stable disease 💠No new safety concerns https://t.co/VGBicnq15w #ACR21 Abst#0817 @RheumNow
      RT @drdavidliew: Interesting question came up: why would you change a RA patient from JAKi to JAKi?

      The main reason I c
      3 years 1 month ago
      Interesting question came up: why would you change a RA patient from JAKi to JAKi? The main reason I can think of would be if the first JAKi worked a bit (but not enough to continue, or AEs got in the way). That would clearly favour to better survival #ACR21 ABST1442 @RheumNow https://t.co/kDiJVbJfit
      RT @RisingAboveRa: Loved this session on: Preclinical Rheumatoid Arthritis- Can we stop RA? As a patient advocate living
      3 years 1 month ago
      Loved this session on: Preclinical Rheumatoid Arthritis- Can we stop RA? As a patient advocate living with RA, my providers have always ran tests on my microbiome. The findings have correlated with my disease flares, and was a big trigger overall. #ACR21 @ACRheum Thank you! https://t.co/6hm6hr85JS
      MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa)

      Dr. Sheila Reyes discusses abstracts #0468 and #0469, prese
      3 years 1 month ago
      MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa) Dr. Sheila Reyes discusses abstracts #0468 and #0469, presented at the #ACR21 annual meeting. https://t.co/MeVia60BNa https://t.co/WRgCifpioQ
      RT @AurelieRheumo: Alcohol and MTX don't go along!
      In a cohort of 1000+ early RA
      Factors associated w/
      1️⃣Nausea
      Fem
      3 years 1 month ago
      Alcohol and MTX don't go along! In a cohort of 1000+ early RA Factors associated w/ 1️⃣Nausea Female OR 2 🍺 Alcohol OR 1.44 DAS28CRP OR 1.16 2️⃣Alopecia Age OR 4.87 🍺 Alcohol OR 1.98 HAQ score OR 1.62 #Abst1444 #ACR21 @RheumNow https://t.co/zZG6aFR1SX
      ×